University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor
Print this page
FONT SIZE
Home > Doctors > Michael Conte

Michael Conte, M.D.

Co-director of the Heart and Vascular Center

Dr. Michael Conte, a vascular surgeon, is co-director of the UCSF Heart and Vascular Center and chief of Vascular and Endovascular Surgery. He specializes in diseases of the aorta and its major branches, aneurysms, carotid artery disease and peripheral artery disease (PAD). He also treats diabetic vascular disease and performs complex revascularization to preserve limb function and prevent amputation. Conte led the largest multi-center clinical trial to date, examining leg bypass surgery in patients with severe PAD and is studying angioplasty and bypass surgery failure and approaches to identify patients at risk.

Conte earned a medical degree at Albert Einstein College of Medicine in New York City. He completed a surgical residency at New York Hospital-Cornell Medical Center and vascular surgery training as a John Homan's Fellow at Brigham and Women's Hospital in Boston and Harvard Medical School. He is a member of the Society for Vascular Surgery and Society of University Surgeons. In 2006, he received the Distinguished Achievement Award from the New York Weill Cornell Medical Center Alumni Council. He serves on the editorial boards for Vascular and Endovascular Surgery, Vascular Medicine, Journal of Vascular Surgery and Vascular.

Clinics

Center for Limb Preservation
400 Parnassus Ave., Room A-6110
San Francisco, CA 94143
Phone: (415) 353-2357
Fax: (415) 353-2669

Hours: Monday to Friday
8 a.m. — 5 p.m.

Vascular and Endovascular Surgery
400 Parnassus Ave., Suite A-6110
San Francisco, CA 94143
Phone: (415) 353-2357
Fax: (415) 353-2669

Hours: Monday to Friday
8 a.m. – 5 p.m.

Vascular Laboratories at Parnassus
505 Parnassus Ave., Eighth Floor, Room M-830A
San Francisco, CA 94143
Phone: (415) 353-1286
Fax: (415) 353-8706

Hours: Monday to Friday
9 a.m. – 5:30 p.m.

Conditions & Treatments

More about Michael Conte

Additional Languages

Spanish

Education

Albert Einstein College of Medicine 1986

Residencies

Cornell Medical Center, General Surgery 1993

Fellowships

Brigham and Women's Hospital, Vascular Surgery 1991
Harvard Medical School, Vascular Surgery 1994
Brigham and Women's Hospital, Vascular Surgery 1994

Selected Research and Publications

  1. Misra S, Lookstein R, Rundback J, Hirsch AT, Hiatt WR, Jaff MR, White CR, Conte M, Geraghty P, Patel M, Rosenfield K. Proceedings from the society of interventional radiology research consensus panel on critical limb ischemia. J Vasc Interv Radiol. 2013 Apr; 24(4):451-8.
  2. Grenon SM, Jeanne M, Aguado-Zuniga J, Conte MS, Hughes-Fulford M. Effects of Gravitational Mechanical Unloading in Endothelial Cells: Association between Caveolins, Inflammation and Adhesion Molecules. Sci Rep. 2013 Mar 20; 3:1494.
  3. Miyahara T, Runge S, Chatterjee A, Chen M, Mottola G, Fitzgerald JM, Serhan CN, Conte MS. D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury. FASEB J. 2013 Jun; 27(6):2220-32.
  4. McPhee JT, Nguyen LL, Ho KJ, Ozaki CK, Conte MS, Belkin M. Risk prediction of 30-day readmission after infrainguinal bypass for critical limb ischemia. J Vasc Surg. 2013 Jun; 57(6):1481-8.
  5. Conte MS. Critical appraisal of surgical revascularization for critical limb ischemia. J Vasc Surg. 2013 Feb; 57(2 Suppl):8S-13S.
  6. Kraiss LW, Conte MS, Geary RL, Kibbe M, Ozaki CK. Setting high-impact clinical research priorities for the Society for Vascular Surgery. J Vasc Surg. 2013 Feb; 57(2):493-500.
  7. Conte MS, Owens CD, Belkin M, Creager MA, Edwards KL, Gasper WJ, Kenagy RD, Leboeuf RC, Sobel M, Clowes A. A single nucleotide polymorphism in the p27(Kip1) gene is associated with primary patency of lower extremity vein bypass grafts. J Vasc Surg. 2013 May; 57(5):1179-1185.e2.
  8. Ehsan A, McGraw AP, Aronovitz MJ, Galayda C, Conte MS, Karas RH, Jaffe IZ. Mineralocorticoid receptor antagonism inhibits vein graft remodeling in mice. J Thorac Cardiovasc Surg. 2013 Jun; 145(6):1642-1649.e1.
  9. Gasper WJ, Owens CD, Kim JM, Hills N, Belkin M, Creager MA, Conte MS. Thirty-day vein remodeling is predictive of midterm graft patency after lower extremity bypass. J Vasc Surg. 2013 Jan; 57(1):9-18.
  10. Subherwal S, Anstrom KJ, Jones WS, Felker MG, Misra S, Conte MS, Hiatt WR, Patel MR. Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia. Am Heart J. 2012 Sep; 164(3):277-84.
  11. Owens CD, Conte MS. Medical management of peripheral arterial disease: bridging the "gap"? Circulation. 2012 Sep 11; 126(11):1319-21.
  12. Hoel AW, Yu P, Nguyen KP, Sui X, Plescia J, Altieri DC, Conte MS. Mitochondrial heat shock protein-90 modulates vascular smooth muscle cell survival and the vascular injury response in vivo. Am J Pathol. 2012 Oct; 181(4):1151-7.
  13. Creager MA, Kaufman JA, Conte MS. Clinical practice. Acute limb ischemia. N Engl J Med. 2012 Jun 7; 366(23):2198-206.
  14. Conte MS. Diabetic revascularization: endovascular versus open bypass--do we have the answer? Semin Vasc Surg. 2012 Jun; 25(2):108-14.
  15. Johnston PC, Vartanian SM, Runge SJ, Hiramoto JS, Eichler CM, Owens CD, Schneider DB, Conte MS. Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease. J Vasc Surg. 2012 Oct; 56(4):998-1006, 1007.e1; discussion 1006-7.
  16. Hiramoto JS, Owens CD, Kim JM, Boscardin J, Belkin M, Creager MA, Conte MS. Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass grafts. J Vasc Surg. 2012 Aug; 56(2):387-95; discussion 395.
  17. Owens CD, Kim JM, Hevelone ND, Gasper WJ, Belkin M, Creager MA, Conte MS. An integrated biochemical prediction model of all-cause mortality in patients undergoing lower extremity bypass surgery for advanced peripheral artery disease. J Vasc Surg. 2012 Sep; 56(3):686-95.
  18. Grenon SM, Aguado-Zuniga J, Hatton JP, Owens CD, Conte MS, Hughes-Fulford M. Effects of fatty acids on endothelial cells: inflammation and monocyte adhesion. J Surg Res. 2012 Sep; 177(1):e35-43.
  19. Grenon SM, Hughes-Fulford M, Rapp J, Conte MS. Polyunsaturated fatty acids and peripheral artery disease. Vasc Med. 2012 Feb; 17(1):51-63.
  20. Oka RK, Conte MS, Owens CD, Rapp J, Fung G, Alley HF, Giacomini JC, Myers J, Mohler ER. Efficacy of optimal long-term management of multiple cardiovascular risk factors (CVD) on walking and quality of life in patients with peripheral artery disease (PAD): protocol for randomized controlled trial. Vasc Med. 2012 Feb; 17(1):17-28.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.

Home • Terms of Use • Site Map • Contact Us       © 2002 - 2013 The Regents of The University of California